Table 2.
The disease characteristic of patients with T2DM and HTN in Hiwot Fana Specialized University Hospital, 2017 (n = 203)
| Disease characteristics | n (%) |
|---|---|
| Duration of DM (years) | |
| < 5 | 62 (30.5) |
| ≥ 5–10 | 109 (53.7) |
| ≥ 10 | 32 (15.8) |
| FBS at last visit (mg/dL) | |
| > 180 | 88 (43.3) |
| 140–180 | 45 (22.2) |
| < 140 | 68 (33.5) |
| BP at last visit | |
| ≤ 140/80 | 138 (67.9) |
| > 140/80 | 65 (32.1) |
| Comorbidity other than HTN (n = 122) | |
| Ischemic heart disease (IHD) | 47 (38.6) |
| Dyslipidaemia | 31 (25.4) |
| Heart failure | 18 (14.7) |
| Peripheral arterial disease | 14 (11.5) |
| Other* | 12 (9.8) |
| T2DM complications (n = 144) | |
| Neuropathy | 45 (31.2) |
| Neuropathy and retinopathy | 31 (21.5) |
| Retinopathy | 25 (17.4) |
| Nephropathy | 23 (16.0) |
| Diabetic foot ulcer | 20 (13.9) |
FBS fasting blood sugar, BP blood pressure
aUrinary tract infection, chronic obstructive pulmonary disease, acute pyelonephritis, portal HTN